Tosca, E. M., Terranova, N., Stuyckens, K., Dosne, A. G., Perera, T., Vialard, J., . . . Poggesi, I. (2022). A translational model-based approach to inform the choice of the dose in phase 1 oncology trials. Cancer Chemotherapy and Pharmacology, 89(1), 117-128. https://doi.org/10.1007/s00280-021-04370-7
Chicago Style (17th ed.) CitationTosca, E. M., et al. "A Translational Model-based Approach to Inform the Choice of the Dose in Phase 1 Oncology Trials." Cancer Chemotherapy and Pharmacology 89, no. 1 (2022): 117-128. https://doi.org/10.1007/s00280-021-04370-7.
MLA (9th ed.) CitationTosca, E. M., et al. "A Translational Model-based Approach to Inform the Choice of the Dose in Phase 1 Oncology Trials." Cancer Chemotherapy and Pharmacology, vol. 89, no. 1, 2022, pp. 117-128, https://doi.org/10.1007/s00280-021-04370-7.